Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 219 of 5804
-
Can a biologic drug help peanut allergy sufferers tolerate nuts?
Disease control Recruiting nowThe proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy (OIT) for the treatment of peanut allergy. Study participation is divided into 3 periods: (…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could an HIV drug soothe stubborn throat reflux?
Disease control Recruiting nowLaryngopharyngeal Reflux (LPR) is a common condition that causes symptoms like chronic cough, throat clearing, hoarseness, and trouble swallowing. If not treated, LPR can lead to long-term throat damage and may increase the risk of throat cancer. More than 20% of the people in th…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New daily pill could shield kids from TB
Prevention Not yet recruitingThis study aims to find the proposed dose of Rifapentine (RPT) taken once daily with Isoniazid (INH) for 28 days to prevent tuberculosis (TB). The study will take place at multiple locations and children under 13 years old will be divided into two groups: one group will include c…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Engineered immune cells take on Platinum-Resistant ovarian cancer
Disease control Recruiting nowThis phase 1 study evaluates the safety, efficacy, and biological activity of GB-5267 in patients with platinum-resistant ovarian cancer.
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Stroke showdown: which clot removal method saves more brain?
Disease control Not yet recruitingThis is a multicenter, open-label, blinded-endpoint, randomized controlled trial comparing super large bore catheter aspiration versus stent retriever thrombectomy as the first-line technique for anterior circulation large vessel occlusion in acute ischemic stroke. Eligible patie…
Phase: NA • Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for lymphoma: immune booster plus chemotherapy trial launches
Disease control Not yet recruitingA Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.
Phase: PHASE2 • Sponsor: Mwanasha Merrill, MD • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New PET scan may tell doctors if chemo wiped out breast cancer without surgery
Diagnosis Recruiting nowThe GATHER trial aim to evaluate the diagnostic performance of \[68Ga\]Ga-NOTA-anti-HER2-sdAb PET/CT in predicting pCR following neoadjuvant chemotherapy. This study is part of the development of new functional, non-invasive approaches with the aim of offering personalized therap…
Phase: PHASE2 • Sponsor: Centre Henri Becquerel • Aim: Diagnosis
Last updated Jul 25, 2026 00:00 UTC
-
New drug aims to melt liver fat and stop scarring in MASH patients
Disease control Not yet recruitingThis study will test a Regeneron study drug called ALN-CIDEB to find out whether it may help treat a liver disease called MASH. In this study, researchers are looking at the effect of ALN-CIDEB on reducing liver fat, liver injury, and liver scarring. The study will compare ALN-C…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
App to prevent postpartum depression tested on 3,000 women
Prevention Recruiting nowThis study is part of the ERC-funded e-Perinatal project and represents a large-scale hybrid type 1 effectiveness-implementation cluster randomized controlled trial. The primary aim is to evaluate the effectiveness of a personalized and complex mobile health (mHealth) interventio…
Phase: NA • Sponsor: University of Seville • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Could two old drugs beat long COVID? new trial aims to find out
Disease control Not yet recruitingThe IMPACT Long Covid Treatment clinical study (IMPACT-LC) is testing two repurposed and previously approved drugs, Maraviroc and Atorvastatin, for the treatment of non-hospitalized subjects with Long COVID. The main goals of the clinical study are to determine if this combinatio…
Phase: PHASE2, PHASE3 • Sponsor: HealthBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could tailoring chemo by age make stem cell transplants safer for MDS patients?
Disease control Not yet recruitingThis study plan aims to enroll adult patients diagnosed with myelodysplastic syndrome (MDS) who are scheduled to receive T-cell-replete haploidentical hematopoietic stem cell transplantation. After obtaining written informed consent, participants will receive either reduced-toxic…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to tame rare nerve disease
Disease control Not yet recruitingThis clinical trial aims to evaluate the safety and efficacy of ripertamab in patients with neuromyelitis optica spectrum disorders (NMOSD). The key research objectives are as follows: 1. To assess the efficacy of ripertamab for the treatment of neuromyelitis optica spectrum dis…
Phase: PHASE1, PHASE2 • Sponsor: Zhongming Qiu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI could spot hidden stroke type that often worsens quickly
Diagnosis Recruiting nowBranch atheromatous disease (BAD)-related stroke is an important subtype of acute ischemic stroke involving penetrating arteries and is associated with early neurological deterioration. Early recognition and standardized diagnosis remain challenging in routine clinical practice b…
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could tiny doses of radiation slow Alzheimer's? a new trial investigates
Disease control Recruiting nowTo evaluate the safety and tolerability of low-dose whole brain radiotherapy (WBRT) delivered as an induction course of 0.3 Gy × 10 fractions (3.0 Gy total) followed by 12 months of monthly maintenance LDRT (0.3 Gy × 10 fractions; 3.0 Gy total) in patients with Alzheimer's diseas…
Phase: PHASE1, PHASE2 • Sponsor: Evan Thomas • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a simple questionnaire spot colorectal cancer before It's too late?
Knowledge-focused Not yet recruitingThis is a multicenter, observational study designed to develop and validate a diagnostic model for colorectal cancer and advanced colorectal neoplasia among adults undergoing routine-care colonoscopy in the Chinese population. The study will enroll adults aged 18 to 80 years who…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New mRNA vaccine aims to shield against RSV
⭐️ VACCINE ⭐️ Not yet recruitingA Phase 1 Study to Evaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 Injection
Phase: PHASE1 • Sponsor: Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 12, 2026 00:00 UTC
-
Can a smaller incision for kidney stone surgery reduce recovery without sacrificing results?
Disease control Recruiting nowKidney stones that are large or complex are often treated with percutaneous nephrolithotomy, also called PCNL. Standard PCNL uses a larger access tract and is effective for removing complex kidney stones, but it may be associated with more bleeding, pain, and recovery burden. Mod…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a simple spray shield cancer patients from radiation burns?
Symptom relief Not yet recruitingTo evaluate the efficacy and safety of superoxide dismutase skin spray for the reducing the acute radiation dermatitis in patients with head and neck malignancies undergoing radiotherapy.
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Could a tiny nerve implant silence sleep apnea without a mask?
Disease control Not yet recruitingThe objective of this study is to evaluate the safety and preliminary effectiveness of an implantable hypoglossal nerve stimulation system for moderate-to-severe obstructive sleep apnea (OSA).
Phase: NA • Sponsor: Beijing Pins Medical Co., Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
Disease control Recruiting nowThis is a multicenter, open-label, Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of domatinostat in combination with sirolimus in adolescents and adults with relapsed or refractory sarcoma and osteosarcoma.
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC